The study from Tulane University found that those living in once-redlined neighborhoods see 15% longer delays in achieving successful viral suppression of HIV compared to those in non-redlined areas.

Tremendous successes have been achieved in treating and caring for people living with HIV and in developing HIV prevention technologies such as pre-exposure prophylaxis (PrEP) and post-exposure ...

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced 48-week findings from the DOLCE study, sponsored by Fundación ...

Recent health data reveals an alarming rise in HIV transmission rate between older men and young women, presenting a complex ...

Once regarded as a crisis, Kenya has made significant strides in combating the disease, reducing new infections by 53 per ...

Psychosexual therapist Dr Catherine Hood says many men struggle to talk about this health issue, which can lead to ...

The strategy, called gene drive, pushes a genetic variant into a population that then retools HSV DNA, which then targets latent, infected neurons. If successful, it would be the second gene therapy ...

and 5 trials in key populations across the U.S., U.K., and France. These studies are intended to contribute additional data in communities where the use of or access to prevention options have ...

Africa has about 25.9 million (65%) of the global burden with Nigeria contributing about 1.9 million making it the fourth ...

City-level hospitals purchase 14 large medical appliances, all from leading international companies, at the CIIE on Friday alongside cooperation on infectious disease management.

Gilead (GILD) announced the upcoming presentation of HIV research findings at the International Congress on Drug Therapy in HIV Infection, ...